Medical Commercial Freezers See Rapid Growth; -86℃ Ultra-Low Temperature Models Grow Over 12% Annually
Release Time:
Apr 27,2026
The rapid development of biomedicine, vaccine R&D, and genetic engineering is driving an explosion in demand for medical commercial freezers, with a compound annual growth rate exceeding 12%, far surpassing the industry average. Medical freezers are categorized into refrigeration (2–8℃ for vaccines/reagents), low temperature (-20 to -40℃ for serum/biological samples), and ultra-low temperature (-60 to -86℃ for cells/gene samples). -86℃ ultra-low temperature freezers use dual-stage compression, precise temperature control (±0.1℃), and multiple safety alarms (power outage/high temperature/door open), suitable for biobanks, research institutions, and high-end hospitals. Domestic technological breakthroughs (such as Aucma's -70℃ models) are breaking foreign monopolies and rapidly increasing market share.
The rapid development of biomedicine, vaccine R&D, and genetic engineering is driving an explosion in demand for medical commercial freezers, with a compound annual growth rate exceeding 12%, far surpassing the industry average. Medical freezers are categorized into refrigeration (2–8℃ for vaccines/reagents), low temperature (-20 to -40℃ for serum/biological samples), and ultra-low temperature (-60 to -86℃ for cells/gene samples). -86℃ ultra-low temperature freezers use dual-stage compression, precise temperature control (±0.1℃), and multiple safety alarms (power outage/high temperature/door open), suitable for biobanks, research institutions, and high-end hospitals. Domestic technological breakthroughs (such as Aucma's -70℃ models) are breaking foreign monopolies and rapidly increasing market share.
Key words:
Latest News
English